Search clinical trials for: androgen independent prostate cancer (AIPC)
Total 89025 results
-
Oncology Specialists, S.C.CompletedProstate CancerUnited States
-
US Oncology ResearchEli Lilly and Company; Oregon Health and Science UniversityCompletedAndrogen-independent Prostate CancerUnited States
-
Oncology Specialists, S.C.CompletedProstate CancerUnited States
-
University of PittsburghOrtho Biotech, Inc.CompletedProstate CancerUnited States
-
NovaceaTerminatedProstate CancerUnited States, Canada, Germany, Romania, Czech Republic, Former Serbia and Montenegro, Hungary, Puerto Rico, Slovakia
-
Oncology Specialists, S.C.Celgene CorporationCompletedProstate CancerUnited States
-
US Oncology ResearchPfizerCompleted
-
Oncology Specialists, S.C.Wyeth is now a wholly owned subsidiary of PfizerCompletedProstate CancerUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterCompletedProstate CancerUnited States
-
SanofiCompleted
-
Merck Sharp & Dohme LLCAriad PharmaceuticalsCompleted
-
NovaceaUnknownNon Small Cell Lung Cancer (NSCLC) | Androgen Independent Prostate Cancer (AIPC)Canada, United States
-
Carolina Research Professionals, LLCBayerCompleted
-
Bostwick LaboratoriesProstate Institute of America; Community Memorial HealthCenter; HemaCare CorporationTerminated
-
DendreonCompleted
-
DendreonCompletedProstate CancerUnited States, Canada
-
DendreonCompletedHormone Refractory Prostate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
MacroGenicsActive, not recruitingMelanoma | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Anal Cancer | Malignant Melanoma | Non-small Cell Carcinoma | Oral Squamous Cell Carcinoma | Small Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and Neck | Castration-Resistant... and other conditionsSpain, Australia, United States, Korea, Republic of, France, United Kingdom, Italy, Belgium, Poland
-
DendreonCompletedMetastatic Androgen Independent Prostate CancerUnited States, Canada
-
Io TherapeuticsCompletedCastration Resistant Prostate CancerUnited States
-
University of UtahBoston University; University of Pennsylvania; Northwestern University; Columbia... and other collaboratorsCompleted
-
BayerCompletedProstate CancerUnited States, Argentina
-
University Health Network, TorontoCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States
-
M.D. Anderson Cancer CenterCelgeneCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedProstate Cancer | Metastatic CancerUnited States
-
M.D. Anderson Cancer CenterNovartisCompleted
-
AmgenCompletedHormone Refractory Prostate Cancer
-
Oncology Specialists, S.C.CompletedProstate CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Incyte CorporationTerminatedProstate CancerUnited States
-
NYU Langone HealthNovartisCompletedProstatic Neoplasms | Prostate CancerUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Novartis PharmaceuticalsCompleted
-
University of Southern CaliforniaNovartis; Genentech, Inc.CompletedProstate CancerUnited States
-
Novartis PharmaceuticalsCompleted
-
SanofiRegeneron PharmaceuticalsCompletedProstatic Neoplasms | Neoplasm MetastasisUnited States, France, Canada, Brazil, Russian Federation, Ukraine, Australia, Netherlands, Portugal, Spain, Sweden, Switzerland, Turkey, Estonia, Singapore, Taiwan, Belgium, Czech Republic, Argentina, Denmark, Hungary, Israel, Italy, United Kingdom and more
-
NYU Langone HealthNovartisTerminatedProstatic Neoplasms | Prostate CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Oregon Health and Science UniversityCompletedProstate Cancer | Metastatic, Androgen Independent Prostate CancerUnited States
-
Columbia UniversityCelgene CorporationCompletedProstate CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedProstatic NeoplasmsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedProstate CancerUnited States
-
OnxeoCompleted
-
Institut Paoli-CalmettesTerminatedAndrogen-independent Prostate CancerFrance
-
Arno TherapeuticsUnknownRecurrent Prostate Cancer | Prostate Cancer | Metastatic Prostate Cancer | Androgen-independent Prostate CancerUnited Kingdom
-
University of Michigan Rogel Cancer CenterNovartisCompleted
-
University of California, San FranciscoNovartisTerminated
-
Genzyme, a Sanofi CompanyCompletedProstate Cancer | Prostate AdenocarcinomaUnited States
-
Watson PharmaceuticalsCompletedProstate CancerUnited States